Therapeutics: Fatty acid synthase (FASN; FAS); epidermal growth factor receptor 2 (HER2; EGFR2; ErbB2; neu)

Cancer

INDICATION: Breast cancer

Cell culture and mouse studies identified an inhibitor of FASN activity that

Read the full 147 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE